| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | -60.1% |
| Cost of Revenue | $1.5M | -69.7% |
| Gross Profit | -$93K | +93.4% |
| R&D Expense | $6.2M | -35.2% |
| SG&A Expense | $33.3M | +77.4% |
| Operating Income | -$41.6M | -1877.9% |
| Pre-tax Income | -$65.4M | -7927.9% |
| Income Tax | $0 | -100.0% |
| Net Income | -$65.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | +1047.6% |
| Accounts Receivable | $870K | — |
| Inventory | $1.8M | +648.9% |
| Current Assets | $8.7M | +1804.3% |
| Total Assets | $12.2M | +83.2% |
| Current Liabilities | $6.8M | +4.8% |
| Long-term Debt | $13.2M | -1.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.1M | -828.8% |
| Capital Expenditures | $23K | -97.6% |
| Investing Cash Flow | -$23K | -100.0% |
| Financing Cash Flow | $18.8M | +106.6% |
| Free Cash Flow | -$16.2M | -498.8% |
| -4355.7% |
| EPS (Basic) | -$4.14 | -109.0% |
| EPS (Diluted) | -$4.14 | +46.6% |
| Total Liabilities |
| $20.8M |
| +11.9% |
| Stockholders' Equity | -$8.6M | +52.6% |